CG Oncology, Inc.

CGON chart

CG Oncology, Inc. news

• CG Oncology poised to enter NMIBC market with s...

  Pluang · Oct 27, 3:44 AM EDT

• CG Oncology: A Second-Mover Advantage In Bladder-Sparing Therapy (NASDAQ:CGON)

  Seeking Alpha · Oct 27, 3:31 AM EDT

• CG Oncology, Inc. Estimates – NASDAQ:CGON

  TradingView · Oct 24, 6:57 PM EDT

• CG Oncology (CGON) CCO Hire Puts Its Launch Valuation Narrative To The Test

  Simply Wall Street · Oct 22, 4:39 AM EDT

• CG Oncology (NasdaqGS:CGON) Stock Forecast & Analyst Predictions

  Simply Wall Street · Oct 21, 3:00 AM EDT

• How Investors May Respond To CG Oncology (CGON) Hiring A Commercial Chief

  Simply Wall Street · Oct 20, 8:49 PM EDT

• CG Oncology prepares to unveil data at NEAUA meeting: Can CGON break above $63.44?

  Traders Union · Oct 20, 3:15 PM EDT

• How Investors May Respond To CG Oncology (CGON) Hiring a CCO Before Potential Bladder Cancer Launch

  Yahoo Finance · Oct 13, 10:10 PM EDT

• CG Oncology Appoints Proven Biopharmaceutical Commercial Leader Isabel Kalofonos as Chief Commercial Officer

  Yahoo Finance · Oct 13, 8:00 AM EDT

• 3 Stocks Call Traders Are Targeting Today

  Yahoo Finance · Sep 11, 11:35 AM EDT

• CG Oncology (CGON) Stock Looks Fully Priced After A 160% Run

  Yahoo Finance · Sep 3, 9:06 AM EDT

• CG Oncology to Present at Upcoming Investor Conferences in September

  Yahoo Finance · Sep 2, 8:00 AM EDT

CG Oncology, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-08-06
• 8-K8-K2026-08-06
• 8-K8-K2026-06-08
• 8-K8-K2026-05-26
• 10-Q10-Q2026-05-08
• 8-K8-K2026-05-08
• DEF 14ADEF 14A2026-04-24
• 8-K8-K2026-04-13
• 10-K10-K2026-02-27
• 8-K8-K2026-02-27
• 8-K8-K2026-01-13
• 8-K8-K2026-01-09

About CG Oncology, Inc.

Ticker

CGON (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

Dallas, TX

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1991792

Frequently asked questions